Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 467 Records) |
Query Trace: Multiple Myeloma[original query] |
---|
Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort. Nucleosides, nucleotides & nucleic acids 2023 9 1-19. Jing Yang, Ling Meng, Yongxin Yang, Hongwei Gao, Honggang Jia |
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma. Scientific reports 2023 9 13 (1): 15792. Marta Dratwa, Piotr ?acina, Aleksandra Butrym, Diana Porzuczek, Grzegorz Mazur, Katarzyna Bogunia-Kub |
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 OF1-OF11. Ciara L Freeman, Reginald Atkins, Indumathy Varadarajan, Meghan Menges, Jeffrey Edelman, Rachid Baz, Jason Brayer, Omar Castaneda Puglianini, Jose Leonel Ochoa-Bayona, Taiga Nishihori, Kenneth H Shain, Bijal Shah, Dung Tsa Chen, Linda Kelley, Domenico Coppola, Melissa Alsina, Scott Antonia, Claudio Anasetti, Frederick L Loc |
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma. Frontiers in cardiovascular medicine 2023 7 10 1181806. Marwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, Gabriel DeAvila, Samuel M Rubinstein, Robert F Cornell, Michael G Fradley, Erin M Siegel, Oliver A Hampton, Ariosto S Silva, Daniel Lenihan, Kenneth H Shain, Rachid C Baz, Yan Go |
Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population. Computers in biology and medicine 2023 7 163 107224. Chunbao Xie, Ling Zhong, Jiangrong Luo, Ji Luo, Yingmiao Wu, Shuai Zheng, Lingxi Jiang, Jianbo Zhang, Yi S |
Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma. Asian Pacific journal of cancer prevention : APJCP 2023 7 24 (7): 2421-2425. Metwaly Ibrahim Mortada, Doaa Shahin, Nashwa Abousamra, Doaa Abdalla Aladle, Shaimaa El-Ashwah, F E I Ghobrial, M A El-Baiomy, Eman A Soliman, Nermeen A Niazy, Mayada A Ghann |
A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. International journal of cancer 2023 7 . Håkon Valen, Rune Becher, Gunn Elisabeth Vist, Jørn Andreas Holme, Ibrahimu Mdala, Ida-Kristin Ørjasaeter Elvsaas, Jan Alexander, Vigdis Underland, Bendik Christian Brinchmann, Tom Kristian Grimsr |
A New Clock is Running for Multiple Myeloma: Circadian Clock Protein-Period 3 (PER-3) Polymorphism. Balkan journal of medical genetics : BJMG 2023 6 25 (2): 37-43. I Serin, S Pehlivan, I Demir, Y Oyac?, M Pehliv |
(Smoldering) multiple myeloma: mismatch between tumor load estimated from bone marrow biopsy at iliac crest and tumor load shown by MRI. Skeletal radiology 2023 6 . Fabian Bauer, Sandra Sauer, Niels Weinhold, Stefan Delorme, Markus Wennma |
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization. International journal of molecular sciences 2023 5 24 (10): . Esther Clavero, José Manuel Sanchez-Maldonado, Angelica Macauda, Rob Ter Horst, Belém Sampaio-Marques, Artur Jurczyszyn, Alyssa Clay-Gilmour, Angelika Stein, Michelle A T Hildebrandt, Niels Weinhold, Gabriele Buda, Ramón García-Sanz, Waldemar Tomczak, Ulla Vogel, Andrés Jerez, Daria Zawirska, Marzena W?tek, Jonathan N Hofmann, Stefano Landi, John J Spinelli, Aleksandra Butrym, Abhishek Kumar, Joaquín Martínez-López, Sara Galimberti, María Eugenia Sarasquete, Edyta Subocz, Elzbieta Iskierka-Ja?d?ewska, Graham G Giles, Malwina Rybicka-Ramos, Marcin Kruszewski, Niels Abildgaard, Francisco García Verdejo, Pedro Sánchez Rovira, Miguel Inacio da Silva Filho, Katalin Kadar, Ma?gorzata Razny, Wendy Cozen, Matteo Pelosini, Manuel Jurado, Parveen Bhatti, Marek Dudzinski, Agnieszka Druzd-Sitek, Enrico Orciuolo, Yang Li, Aaron D Norman, Jan Maciej Zaucha, Rui Manuel Reis, Miroslaw Markiewicz, Juan José Rodríguez Sevilla, Vibeke Andersen, Krzysztof Jamroziak, Kari Hemminki, Sonja I Berndt, Vicent Rajkumar, Grzegorz Mazur, Shaji K Kumar, Paula Ludovico, Arnon Nagler, Stephen J Chanock, Charles Dumontet, Mitchell J Machiela, Judit Varkonyi, Nicola J Camp, Elad Ziv, Annette Juul Vangsted, Elizabeth E Brown, Daniele Campa, Celine M Vachon, Mihai G Netea, Federico Canzian, Asta Försti, Juan Sai |
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma. Frontiers in immunology 2023 5 14 1125357. Qiqi Zhang, Cheng Zu, Ruirui Jing, Youqin Feng, Yanlei Zhang, Mingming Zhang, Yuqi Lv, Jiazhen Cui, Linhui Zhou, Ye Meng, Linqin Wang, Zenan Cen, Alex H Chang, Yongxian Hu, He Hua |
Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1. Biomarker research 2023 5 11 (1): 52. Xiang Zhou, Seungbin Han, Nadine Cebulla, Larissa Haertle, Maximilian J Steinhardt, Daniel Schirmer, Eva Runau, Leon Flamm, Calvin Terhorst, Laura Jähnel, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Emilia Stanojkovska, Julia Mersi, Umair Munawar, Magnus Schindehütte, Robert Blum, Ann-Kristin Reinhold, Oliver Scherf-Clavel, Heike L Rittner, Mirko Pham, Leo Rasche, Hermann Einsele, Claudia Sommer, K Martin Kort |
Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses. Oncogene 2023 4 . Flietner Evan, Yu Mei, Poudel Govinda, Veltri Anthony J, Zhou Yun, Rajagopalan Adhithi, Feng Yubin, Lasho Terra, Wen Zhi, Sun Yuqian, Patnaik Mrinal M, Callander Natalie S, Asimakopoulos Fotis, Wang Demin, Zhang Ji |
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nature medicine 2023 4 . Subbiah Vivek, Kreitman Robert J, Wainberg Zev A, Gazzah Anas, Lassen Ulrik, Stein Alexander, Wen Patrick Y, Dietrich Sascha, de Jonge Maja J A, Blay Jean-Yves, Italiano Antoine, Yonemori Kan, Cho Daniel C, de Vos Filip Y F L, Moreau Philippe, Fernandez Elena Elez, Schellens Jan H M, Zielinski Christoph C, Redhu Suman, Boran Aislyn, Passos Vanessa Q, Ilankumaran Palanichamy, Bang Yung-J |
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells 2023 4 12 (7): . Szudy-Szczyrek Aneta, Mlak Rados?aw, Mazurek Marcin, Krajka Tomasz, Chocholska Sylwia, Bitkowska Paulina, Jutrzenka Marta, Szczyrek Micha?, Homa-Mlak Iwona, Krajka Andrzej, Ma?ecka-Massalska Teresa, Hus Mar |
GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis. International journal of molecular sciences 2023 4 24 (7): . Sánchez-Maldonado José Manuel, Cabrera-Serrano Antonio José, Chattopadhyay Subhayan, Campa Daniele, Garrido María Del Pilar, Macauda Angelica, Ter Horst Rob, Jerez Andrés, Netea Mihai G, Li Yang, Hemminki Kari, Canzian Federico, Försti Asta, Sainz Ju |
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 2023 3 12 (6): . Popek-Marciniec Sylwia, Styk Wojciech, Wojcierowska-Litwin Magdalena, Szudy-Szczyrek Aneta, Dudek Paul, Swiderska-Kolacz Grazyna, Czerwik-Marcinkowska Joanna, Zmorzynski Szym |
Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study. Frontiers in oncology 2023 3 13 1110693. Wang Yu-Tong, Chu Bin, Zhou Tian-Guan, Lu Min-Qiu, Shi Lei, Gao Shan, Fang Li-Juan, Xiang Qiu-Qing, Zhao Xin-, Wang Meng-Zhen, Sun Kai, Bao |
Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma. Blood cancer journal 2023 3 13 (1): 43. Evers Marietheres, Schreder Martin, Stühmer Thorsten, Jundt Franziska, Ebert Regina, Hartmann Tanja Nicole, Altenbuchinger Michael, Rudelius Martina, Kuric Martin, Rindt Wyonna Darleen, Steinbrunn Torsten, Langer Christian, Heredia-Guerrero Sofia Catalina, Einsele Hermann, Bargou Ralf Christian, Rosenwald Andreas, Leich Ell |
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 2023 2 13 (1): 31. Moscvin Maria, Liacos Christine Ivy, Chen Tianzeng, Theodorakakou Foteini, Fotiou Despina, Hossain Shahrier, Rowell Sean, Leblebjian Houry, Regan Eileen, Czarnecki Peter, Bagnoli Filippo, Bolli Niccolo', Richardson Paul, Rennke Helmut G, Dimopoulos Meletios A, Kastritis Efstathios, Bianchi Gia |
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories. Frontiers in oncology 2023 2 13 1123029. Gkoliou Glykeria, Agathangelidis Andreas, Karakatsoulis Georgos, Lalayanni Chrysavgi, Papalexandri Apostolia, Medina Alejandro, Genuardi Elisa, Chlichlia Katerina, Hatjiharissi Evdoxia, Papaioannou Maria, Terpos Evangelos, Jimenez Cristina, Sakellari Ioanna, Ferrero Simone, Ladetto Marco, Sanz Ramon Garcia, Belessi Chrysoula, Stamatopoulos Kost |
DIS3: The Enigmatic Gene in Multiple Myeloma. International journal of molecular sciences 2023 2 24 (4): . Ohguchi Yasuyo, Ohguchi Hiro |
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. Blood advances 2023 2 . Kleman Ariel, Singavi Arun K, Pommert Lauren, Mathison Angela Joy, Hari Parameswaran, Dhakal Binod, Mohan Meera, Janz Siegfried, Knight Jennifer Mary, Shah Mithun Vinod, Schinke Carolina, Burns Robert Thomas, Steinhardt George Francis, Rao Sridhar, Carlson Karen-Sue Bark |
Serum IL-17 and TNF? as prognostic biomarkers in systemic sclerosis patients: a prospective study. Rheumatology international 2023 12 . Joanna Kosa?ka-W?giel, Sabina Licho?ai, Renata Pacholczak-Madej, Sylwia Dziedzina, Mamert Milewski, Piotr Kuszmiersz, Anna Korona, Jolanta G?sior, Aleksandra Matyja-Bednarczyk, Helena Kwiatkowska, Lech Zar?ba, And?elika Siwiec-Ko?lik, Pawe? Ko?lik-Siwiec, Anita Wach, Weronika Pociej-Marciak, Marek Sanak, Jacek Musia?, Stanis?awa Bazan-Socha, Mariusz Korko |
Impact of rare structural variant events in newly diagnosed multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 . Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, Even Rustad, Kylee Maclachlan, Marios Papadimitriou, Eileen M Boyle, Patrick Blaney, Saad Usmani, Gareth Morgan, Ola Landgren, Francesco Mau |
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. Frontiers in immunology 2023 11 14 1286700. Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Salwender, Uta Bertsch, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S Raab, Hartmut Goldschmidt, Anna Jauch, Ken Maes, Elke De Bruyne, Eline Menu, Kim De Veirman, Jérôme Moreaux, Karin Vanderkerken, Anja Seckinger, Dirk Ho |
Sunlight, vitamin D, vitamin D receptor polymorphisms, and risk of multiple myeloma: A systematic review. Cancer epidemiology 2023 11 87 102488. Simon Cheah, Dallas R English, Simon J Harrison, Claire M Vajdic, Graham G Giles, Roger L Mil |
The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma. Leukemia research reports 2023 11 20 100393. A-M Joëlle Marivel, Yafeng Ma, Therese M Becker, Anvita Verma, Steven Trieu, Tara L Roberts, Silvia C W Li |
IL1B Polymorphism (rs1143634) and IL-1? Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients. Cancers 2024 4 16 (7): . Marcin Mazurek, Aneta Szudy-Szczyrek, Iwona Homa-Mlak, Marek Hus, Teresa Ma?ecka-Massalska, Rados?aw Ml |
Identifying Determinants of Survival Disparities in Multiple Myeloma Patients Using Electronic Health Record Data. Studies in health technology and informatics 2024 1 310 956-960. Wanting Cui, Joseph Finkelste |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: